Published • loading... • Updated
Deadline Fast Approaching for Canadians to File Claims in Class-Action Drug Suit
- Canadians have a deadline of August 27 to file claims in a $4.75 million class-action settlement regarding the drug Rexulti, which is used to treat schizophrenia and depression.
- The Quebec Superior Court approved the settlement in November after authorizing the national class action against Otsuka Canada Pharmaceutical Inc. and Lundbeck Canada Inc..
- The class action includes Canadians prescribed Rexulti since February 2017 who developed compulsive behaviors or impulse-control disorders such as gambling, shopping, or binge-eating.
- Affected individuals may receive settlements ranging from about $6,500 for mild cases to over $102,000 for more severe cases, with lawyers noting the deal is a compromise without admission of liability.
Insights by Ground AI
32 Articles
32 Articles
Shine gets extension to serve class actions over stomach acid drugs
Save (0) Please login to bookmarkClose Username or Email Address Password Remember Me Shine Lawyers has won a 12-month extension to serve class actions three against drug companies that sell proton pump inhibitors. Subscribe to Lawyerly to access this article.Already a subscriber? Username or Email Address Password Remember Me Lost your password? The post Shine gets extension to serve class actions over stom…
The Toronto Star+25 Reposted by 25 other sources
Deadline fast approaching for Canadians to file claim in class-action drug suit
MONTREAL - The deadline is fast approaching for Canadians to claim their share of a multimillion-dollar class-action lawsuit over the drug Rexulti.
·Toronto, Canada
Read Full ArticleCoverage Details
Total News Sources32
Leaning Left19Leaning Right1Center12Last UpdatedBias Distribution59% Left
Bias Distribution
- 59% of the sources lean Left
59% Left
L 59%
C 38%
Factuality
To view factuality data please Upgrade to Premium
